STOCK TITAN

Tenet Healthcare: BlackRock holds 10% stake

BlackRock reports beneficial ownership of 10.0% of Tenet Healthcare’s common stock with sole voting and dispositive power over the position.

(Moderate)
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

TENET HEALTHCARE CORPORATION (THC) is reported to have 8,083,830 shares of its common stock beneficially owned by BlackRock, Inc. under an amended Schedule 13G filing. As of August 31, 2026, this position represents 10.0% of Tenet Healthcare’s common stock outstanding.

BlackRock reports sole voting power over 7,837,557 shares and sole dispositive power over all 8,083,830 shares, with no shared voting or dispositive power. Various underlying clients or accounts have rights to dividends or sale proceeds, but no single person has more than five percent of Tenet Healthcare’s outstanding common shares.

Positive

  • None.

Negative

  • None.
Shares beneficially owned 8,083,830 shares Tenet Healthcare common stock beneficially owned by BlackRock as reported in Item 4(a)
Percent of class 10.0% Percentage of Tenet Healthcare common stock represented by BlackRock’s beneficial ownership
Sole voting power 7,837,557 shares Shares of Tenet Healthcare for which BlackRock has sole power to vote or direct the vote
Shared voting power 0 shares Shares of Tenet Healthcare for which BlackRock has shared voting power
Sole dispositive power 8,083,830 shares Shares of Tenet Healthcare for which BlackRock has sole power to dispose or direct disposition
Shared dispositive power 0 shares Shares of Tenet Healthcare for which BlackRock has shared dispositive power
beneficially owned financial
"this reflects the securities beneficially owned, or deemed to be beneficially owned"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
Sole Voting Power financial
"5 | Sole Voting Power 7,837,557.00"
Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.
Sole Dispositive Power financial
"7 | Sole Dispositive Power 8,083,830.00"
Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.
Schedule 13G regulatory
"this schedule has been filed pursuant to Schedule 13G"
A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.
Power of Attorney regulatory
"Exhibit 24: Power of Attorney"
A power of attorney is a legal document that allows one person to make decisions and act on behalf of another person, often in financial or legal matters. It’s like giving someone a trusted helper or agent the authority to handle important tasks if you are unable to do so yourself. This matters to investors because it can impact how their assets are managed or transferred if they become unable to oversee their affairs.

FAQ

What percentage of TENET HEALTHCARE (THC) shares does BlackRock report owning?

BlackRock reports 10.0% beneficial ownership of Tenet Healthcare common stock, based on 8,083,830 shares. This percentage reflects its position as of August 31, 2026, as disclosed in the amended Schedule 13G filing.

How many TENET HEALTHCARE (THC) shares does BlackRock have voting power over?

BlackRock reports sole voting power over 7,837,557 shares of Tenet Healthcare common stock and no shared voting power. It therefore alone directs how these shares are voted.

How many TENET HEALTHCARE (THC) shares can BlackRock dispose of?

BlackRock reports sole dispositive power over 8,083,830 shares of Tenet Healthcare common stock and no shared dispositive power. This means it can alone decide whether and how to sell or otherwise dispose of these shares.

Do any underlying investors hold more than 5% of TENET HEALTHCARE (THC) through BlackRock?

No. The filing states that various persons may receive dividends or sale proceeds for Tenet Healthcare shares managed by BlackRock, but no one person’s interest exceeds five percent of Tenet’s total outstanding common shares.

Who signed the amended Schedule 13G filing for TENET HEALTHCARE (THC)?

The filing was signed by Spencer Fleming, identified as a Managing Director of BlackRock, Inc., dated September 4, 2026. The filing also references a Power of Attorney as Exhibit 24.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates





88033G407

(CUSIP Number)
08/31/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G



BlackRock, Inc.
Signature:Spencer Fleming
Name/Title:Managing Director
Date:09/04/2026
Exhibit Information

Exhibit 24: Power of Attorney Exhibit 99: Item 7

Keep reading